- link Copy URL
- [     Share on X ](https://twitter.com/intent/tweet?text=Eli Lilly: Searching for New Tuberculosis Drugs https://www.3blmedia.com/markdownify/node/51244?absolute=1&via=3blnews "Share on X")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/51244?absolute=1 "Share on Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/51244?absolute=1 "Share on Facebook")
- [ email Share via email ](mailto:?subject=Eli Lilly: Searching for New Tuberculosis Drugs&body=ESG News from GBCHealth  https://www.3blmedia.com/markdownify/node/51244?absolute=1 "Share via email")
 
 

 [Health & Healthcare](/categories/health-healthcare)

 # Eli Lilly: Searching for New Tuberculosis Drugs

 


 

 Oct 14, 2014 3:45 PM ET

  ![](https://3blcdn.com/styles/carousel_2x/s3/2026-08/Lilly-edited_1786917873.jpg)

 

[Originally published on GBCHealth.org](http://bit.ly/1z80GY7)

Most TB drugs currently approved for treatment are 50+ years old and are required to be taken over a 6-month period to be effective. Compliance with such a long treatment regimen is a challenge, limiting drugs’ effectiveness and contributing to the rise in MDR-TB. As part of its MDR-TB Partnership, Eli Lilly and Company formed innovative partnerships with the Infectious Disease Research Institute (IDRI) and the Bill and Melinda Gates Foundation to discover new and more effective TB drugs. These partnerships draw on the expertise of private sector companies like Lilly and seek multi-sector solutions to accelerate progress in the fight against TB. [Learn more about Lilly’s partnership with IDRI here.](https://www.youtube.com/watch?v=KUso0onZiLc)

**Lilly TB Drug Discovery Initiative**

Lilly launched its TB Drug Discovery Initiative in partnership with the Infectious Disease Research Institute (IDRI) and the National Institutes of Health (NIH/NIAID) in 2007. Formed as a public-private partnership with representatives from governments, philanthropic organizations, pharmaceutical companies, universities, and other research institutions, the initiative aims to fill the pipeline with new TB drugs.

**[Continue reading on GBCHealth.org >>](http://bit.ly/1z80GY7)**



 

 

 

 

 

 

 

 [![GBCHealth logo](/sites/default/files/Clients/Screen%20Shot%202013-02-25%20at%209.44.43%20AM.png)](/profiles/gbchealth)

 

 

### More from GBCHealth 

###### [Global Innovators Shaping the Future, United](/news/global-innovators-shaping-future)

 Sep 19, 2023 9:00 PM ET

  



###### [Awarding the African Innovators Shaping the Future of Health](/news/awarding-african-innovators-shaping-future-health)

 May 15, 2023 9:45 AM ET

  



###### [Help Us Highlight Africa’s Health Heroes](/news/help-us-highlight-africas-health-heroes)

 Mar 13, 2023 8:30 AM ET

  



###### [Provocateurs, Lodestars, Futurists, Multipliers & Collaborators Shaping the Future of Global Health](/news/provocateurs-lodestars-futurists-multipliers-collaborators-shaping-future-global-health)

 Sep 30, 2022 11:00 AM ET

  



###### [New Private Sector Commitments to the End Malaria Project Announced](/news/new-private-sector-commitments-end-malaria-project-announced)

 May 21, 2021 4:00 AM ET

  



###### [Ensuring Progress in the Fight to End Malaria Through Innovation & Collaboration](/news/ensuring-progress-fight-end-malaria-through-innovation-collaboration)

 Apr 27, 2021 12:10 PM ET

  



###### [Former Access Bank CEO, Aigboje Aig-Imoukhuede, to Release New Book Leaving the Tarmac: Buying a Bank in Africa and Launch His Family Philanthropic Foundation](/news/former-access-bank-ceo-aigboje-aig-imoukhuede-release-new-book-leaving-tarmac-buying-bank)

 Mar 29, 2021 9:20 AM ET

  



###### [Transition at the Top: GBCHealth Appoints Lesley-Anne Long as New President and Chief Executive Officer](/news/transition-top-gbchealth-appoints-lesley-anne-long-new-president-and-chief-executive-officer)

 Feb 16, 2021 6:00 AM ET